Literature DB >> 8083369

Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

M L Hartman1, S M Pincus, M L Johnson, D H Matthews, L M Faunt, M L Vance, M O Thorner, J D Veldhuis.   

Abstract

Pulses of growth hormone (GH) release in acromegaly may arise from hypothalamic regulation or from random events intrinsic to adenomatous tissue. To distinguish between these possibilities, serum GH concentrations were measured at 5-min intervals for 24 h in acromegalic men and women with active (n = 19) and inactive (n = 9) disease and in normal young adults in the fed (n = 20) and fasted (n = 16) states. Daily GH secretion rates, calculated by deconvolution analysis, were greater in patients with active acromegaly than in fed (P < 0.05) but not fasted normal subjects. Significant basal (nonpulsatile) GH secretion was present in virtually all active acromegalics but not those in remission or in fed and fasted normal subjects. A recently introduced scale- and model-independent statistic, approximate entropy (ApEn), was used to test for regularity (orderliness) in the GH data. All but one acromegalic had ApEn values greater than the absolute range in normal subjects, indicating reduced orderliness of GH release; ApEn distinguished acromegalic from normal GH secretion (fed, P < 10(-12); fasted, P < 10(-7)) with high sensitivity (95%) and specificity (100%). Acromegalics in remission had ApEn scores larger than those of normal subjects (P < 0.0001) but smaller than those of active acromegalics (P < 0.001). The coefficient of variation of successive incremental changes in GH concentrations was significantly lower in acromegalics than in normal subjects (P < 0.001). Fourier analysis in acromegalics revealed reduced fractional amplitudes compared to normal subjects (P < 0.05). We conclude that GH secretion in acromegaly is highly irregular with disorderly release accompanying significant basal secretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083369      PMCID: PMC295213          DOI: 10.1172/JCI117446

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Approximate entropy as a measure of system complexity.

Authors:  S M Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  Deconvolution analysis of hormone data.

Authors:  J D Veldhuis; M L Johnson
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

3.  Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.

Authors:  A Beckers; A Stevenaert; J M Foidart; G Hennen; F Frankenne
Journal:  J Clin Endocrinol Metab       Date:  1990-09       Impact factor: 5.958

4.  Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.

Authors:  S S Yen; T M Siler; G W DeVane
Journal:  N Engl J Med       Date:  1974-04-25       Impact factor: 91.245

5.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

6.  Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses.

Authors:  C A Jaffe; R D Friberg; A L Barkan
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Temporal structure of in vivo growth hormone secretory events in humans.

Authors:  M L Hartman; A C Faria; M L Vance; M L Johnson; M O Thorner; J D Veldhuis
Journal:  Am J Physiol       Date:  1991-01

8.  Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.

Authors:  L J Hofland; P M van Koetsveld; C C van Vroonhoven; S Z Stefanko; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1989-03       Impact factor: 5.958

9.  Abnormalities of the human growth hormone gene and protooncogenes in some human pituitary adenomas.

Authors:  H S U; P Kelley; W H Lee
Journal:  Mol Endocrinol       Date:  1988-01

10.  Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone.

Authors:  R G Thompson; A Rodriguez; A Kowarski; R M Blizzard
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

View more
  39 in total

1.  Experimentally induced androgen depletion accentuates ethnicity-related contrasts in luteinizing hormone secretion in asian and caucasian men.

Authors:  Johannes D Veldhuis; Anthony Bae; Ronald S Swerdloff; Ali Iranmanesh; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

2.  Adaptive computation of approximate entropy and its application in integrative analysis of irregularity of heart rate variability and intracranial pressure signals.

Authors:  Xiao Hu; Chad Miller; Paul Vespa; Marvin Bergsneider
Journal:  Med Eng Phys       Date:  2007-08-21       Impact factor: 2.242

3.  Biomathematical modeling of pulsatile hormone secretion: a historical perspective.

Authors:  William S Evans; Leon S Farhy; Michael L Johnson
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 4.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

5.  Oscillations in joint synchrony of reproductive hormones in healthy men.

Authors:  Xin Wang; Daniel M Keenan; Steven M Pincus; Peter Y Liu; Johannes D Veldhuis
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-06       Impact factor: 4.310

6.  Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males.

Authors:  S M Pincus; T Mulligan; A Iranmanesh; S Gheorghiu; M Godschalk; J D Veldhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome.

Authors:  M O van Aken; A M Pereira; S W van Thiel; G van den Berg; M Frölich; J D Veldhuis; J A Romijn; F Roelfsema
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

8.  A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans.

Authors:  Johannes D Veldhuis; Martin Bidlingmaier; Joy Bailey; Dana Erickson; Paola Sandroni
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

9.  Randomness and degrees of irregularity.

Authors:  S Pincus; B H Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

10.  Pituitary-hormone secretion by thyrotropinomas.

Authors:  Ferdinand Roelfsema; Simon Kok; Petra Kok; Alberto M Pereira; Nienke R Biermasz; Jan W Smit; Marijke Frolich; Daniel M Keenan; Johannes D Veldhuis; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.